Skip to main content
Clinical Trials/ISRCTN09267489
ISRCTN09267489
Terminated
N/A

A randomised controlled trial to investigate the effectiveness of the healthy sexual functioning module and selective serotonin reuptake inhibitor medication to treat deviant sexual arousal as part of the HM prison sex offender treatment programme

Department of Health (UK)0 sites480 target enrollmentJune 7, 2006

Overview

Phase
N/A
Intervention
Not specified
Conditions
Deviant sexual arousal
Sponsor
Department of Health (UK)
Enrollment
480
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 7, 2006
End Date
September 1, 2009
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • Consent to treatment in HSF module of HM prison sex offender treatment programme with written informed consent.
  • In addition, for SSRI sub\-study, any one of the following:
  • 1\. Sexual preoccupation (either from clinical assessment or based on the multiphasic sex inventory \[MSI] obsession scale)
  • 2\. A compulsive aspect to their offending (based on clinical judgement)
  • 3\. Mood state being an important contributor to their offending (based on clinical judgement)
  • 4\. Impulsivity (based on clinical judgement or impulsivity score)

Exclusion Criteria

  • HSF evaluation: urgent treatment need as assessed by the treatment manager
  • SSRI sub\-study only:
  • 1\. Presence of psychotic disorder or major mood disorder, epilepsy, uncontrolled seizure disorders, diabetes, major cardiac problems or severe renal failure.
  • 2\. Concomitant treatment with psychoactive medication which may interact with the effects of the SSRI e.g. neuroleptic or antidepressant medication
  • 3\. Concomitant treatment with an anti\-androgen
  • 4\. Concomitant treatment with an anti\-coagulant
  • 5\. Current treatment, or treatment within the last 4 weeks with SSRI
  • 6\. Previous adverse reaction to an SSRI

Outcomes

Primary Outcomes

Not specified

Similar Trials